{site_meta && site_meta.display_name} Logo

NewMediaWire

NewMediaWire distributes press releases on behalf of hundreds of publicly traded companies, as well as private corporations, non-profits and other public sector organizations. Founded and staffed by industry veterans, we offer a full complement of services including specialized delivery to financial sites and posting of photos and multimedia content. In addition, NewMediawire offers international and specialized services such as IR websites and industry specific distribution.

RSS Feed for NewMediaWire

Nabaltec AG: Dirk A. Muller Succeeds Gunther Spitzer as the New Chief Financial Officer; CEO's Contract Extended by Five Years

March 17, 2026SCHWANDORF, GERMANY - March 17, 2026 (NEWMEDIAWIRE) - Nabaltec AG has announced a change in its Management Board. Gunther Spitzer, who has been a member of Nabaltec AG's three-member Management Board as Chief Financial Officer (CFO) since 2017, will not extend his contract, which expires on 31 December 2026, and will retire at his own request after nearly 45 years with the company.


Extra Belly Weight, Not BMI, Was a Stronger Predictor of Heart Failure Risk, Inflammation

March 17, 2026Research Highlights: Excess fat stored around the waist (belly weight or visceral fat), indicated by measuring waist size, was more strongly associated with heart failure risk than body mass index (BMI). Systemic inflammation played a key role in the relationship between extra weight stored around the waist, or central obesity, and heart failure.


Type 2 Diabetes Risk Varied Widely Among Adults 18-40 With Prediabetes

March 17, 2026Research Highlights: Adults with prediabetes by their early 30s who had high fasting glucose levels, in addition to other risk factors such as obesity, high cholesterol or high blood pressure, had the highest risk of developing Type 2 diabetes. Individuals who had high fasting glucose levels (100-125 mg/dL) and who met the criteria for treatment with a GLP-1RA medication were more likely to progress from prediabetes to Type 2 diabetes within five years.


FILMART and EntertainmentPulse Open Today

March 17, 2026- Record number of participating countries and regions drives global exchange and collaboration in film and entertainment content HONG KONG, - March 17, 2026 (NEWMEDIAWIRE) - The 30th Hong Kong International Film and TV Market (FILMART) and EntertainmentPulse, organised by the Hong Kong Trade Development Council (HKTDC), is taking place from March 17 to 20 at the Hong Kong Convention and Exhibition Centre. The four-day event gathers global film and entertainment industry leaders to showcase new productions and cutting-edge technologies, while fostering discussions on international market trends and opportunities.


Andina Copper Intersects Wide Cu-Au-Ag Mineralization at Piuquenes East

March 17, 2026VANCOUVER, BC - March 17, 2026 (NEWMEDIAWIRE) - Andina Copper Corp. (TSX-V:ANDC) (FSE:FIR) (OTCQB:PMMCF) is pleased to report a wide intercept of copper-gold-silver mineralization at Piuquenes East that significantly expands the vertical extent of the mineralized envelope and confirms increasing gold grades and intensity of porphyry stockwork veining laterally and to depth.


Critical Infrastructure Technologies to Enter a JV to Develop and Deploy an Arctic-Focused Autonomous Nexus Platform

March 17, 2026Critical Infrastructure Technologies to Enter a JV to Develop and Deploy an Arctic-Focused Autonomous Nexus Platform KEY HIGHLIGHTS: - Joint Venture will be established to develop and commercialise an Arctic-ready Nexus platform - Establishment of a British Columbia facility to support integration and Arctic testing - Development of the Arctic Nexus platform to support Arctic communications and surveillance deployments across defence and industrial markets VANCOUVER, BC - March 17, 2026 (NEWMEDIAWIRE) - Critical Infrastructure Technologies Ltd. (CSE: CTTT) (OTC: CITLF) (FRA: X9V) (“CiTech” or the “Company”), a developer of autonomous, high-capacity mobile communications and security platforms, is pleased to announce that it will co-develop and commercialise an Arctic-ready version of the Company’s Nexus platform under a JV arrangement.


tZERO Launches Halo: A New Standard for AI-Powered Digital Asset Transactions

March 17, 2026New Tool Allows Users to Connect AI Agents to Digital Asset Wallets With Configurable Parameters for Payments, Transfers, and Trading NEW YORK, NY - March 17, 2026 (NEWMEDIAWIRE) - tZERO Group, Inc. , a leading innovator in blockchain-powered multi-asset infrastructure, today announced the beta launch of tZERO Halo - a first-of-its-kind tool designed to give AI agents the ability to transact with digital assets on behalf of users within a framework of security parameters defined by the account holder.


ADM Endeavors (OTCQB: ADMQ) Receives Certificate of Occupancy for New $13 Million, 100,000-Square-Foot Production and Retail Facility

March 17, 2026FORT WORTH, TX - March 17, 2026 (NEWMEDIAWIRE) - Just Right Products Inc. , a wholly owned subsidiary of ADM Endeavors ("ADM" or the "Company") (OTCQB: ADMQ), announced that on March 6, 2026, the City of Fort Worth Building Code Department issued a Certificate of Occupancy for the company’s new $13 million, 100,000-square-foot production and retail facility, which is approximately 5.


NeuroOne® Announces Publication of Clinical Experience With Its OneRF® sEEG-Guided Radiofrequency Ablation Technology

March 17, 2026Peer-Reviewed Case Series Supports Safe Integration into Existing Stereotactic Workflow, Bedside Treatment Capability, and Reductions in Seizure Burden in Patients with Drug-Resistant Epilepsy* EDEN PRAIRIE, MINN. - March 17, 2026 (NEWMEDIAWIRE) - NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company dedicated to transforming the surgical diagnosis and treatment of neurological disorders, today announced the peer-reviewed publication entitled, “Initial clinical experience with the first FDA-approved sEEG-guided radiofrequency ablation system featuring real-time temperature monitoring: A case series (Zavala et al.


Pride Holdings Group Announces Return of 13.35% of Outstanding Shares to Treasury, Strengthening Capital Structure and Reinforcing Long-Term Shareholder Commitment

March 17, 2026ORLANDO, FL - March 17, 2026 (NEWMEDIAWIRE) - Pride Holdings Group (OTC: PHSE), a diversified hospitality, entertainment, and LGBTQ+ focused holding company, today announced that its former Chief Executive Officer has voluntarily returned approximately 13. 35% of the company’s outstanding shares issued to the company’s treasury.


Sartorius Launches Next-generation Platform to Boost Efficiency in Cell Therapy Production

March 16, 2026 Eveo Cell Therapy Platform enables automated, multi-parallel intensified production of autologous cell therapies Compact design can increase output up to fourfold in existing cleanroom space 90 percent reduction in manufacturing costs possible in CAR-T processes Successful pilot project with CDMO ElevateBio proves applicability GOTTINGEN, GERMANY - March 16, 2026 (NEWMEDIAWIRE) - The life science group Sartorius is launching an integrated system for the production and quality control (QC) of autologous cell therapies. The modular Eveo Cell Therapy Platform is designed to address structural manufacturing bottlenecks that limit scalability and patient access to transformative treatments such as CAR-T therapies.


naoo Bridges Digital Engagement and Local Commerce With Launch of Generation V

March 16, 2026 New platform release enables local activation, merchant integration and measurable real-world interaction ZUG and ZURICH, SWITZERLAND - March 16, 2026 (NEWMEDIAWIRE) - naoo AG (Dusseldorf: Ticker: NAO; ISIN: CH1323306329), operator of the social media and commerce platform naoo, announces the launch of naoo Generation V. and confirms that naoo business, previously communicated for rollout in Q1 2026, will be live within the new platform environment.


Helix BioPharma Corp. Announces Financial Results and Filing of Interim Financial Statements as of and for the Three- and Six-Month Periods Ended January 31, 2026

March 16, 2026TORONTO, ONTARIO - March 16, 2026 (NEWMEDIAWIRE) - Helix BioPharma Corp. (TSX: “HBP”, OTC PINK: “HBPCD”, FRANKFURT: “HBP0”) (“Helix” or the “Company”), a clinical-stage oncology company shaping a near future where today’s hard-to-treat cancers are vincible, today reported financial results and the filing of the Company’s unaudited interim financial statements as of and for the three- and six-month periods ended January 31, 2026 (the “Financial Statements”), the management’s discussion and analysis (“MD&A”), and the certifications of the Chief Executive Officer and Chief Financial Officer (respectively, “CEO” and “CFO”) relating to the Financial Statements (collectively, the “Interim Filings”).